NCT06580314 2026-03-24
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
NRG Oncology
Phase 3 Recruiting
NRG Oncology
The Netherlands Cancer Institute
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, Naples
University College, London
Arcagy Research